CCTA/CECT, IR, CAG+/-PCI
Conditions
Interventions
none:none
Sponsors
Fu wai Cardiovascular Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Patients who were referred to the study sites for CECT/CCTA, IR, CAG and/or PCI and who had given written informed consent to have their data collected for the study were enrolled. The patients enrolled were 18 years of age or older, patients had no contraindications according to the SPC for VISIPAQUE 270/320 mgI/ml in China.
Exclusion criteria
Exclusion criteria: Patients with uncontrollable hyperthyroidism and has serious adverse reaction; History of Iodixanol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| allergic, non-allergic adverse drug reaction (such as hot/cool/pain/uncomfortable); | — |
Countries
China
Contacts
Public ContactLu Bin
Outcome results
None listed